TY  - JOUR
TI  - Folfiri Plus Panitumumab as the First-Line Treatment in Patients with KRAS Wild-Type Metastatic Colorectal Cancer. A Single Center Experience
AU  - Geredeli, Ç.
JO  - European Archives of Medical Research
PY  - 2018
VL  - 34
SP  - 98
EP  - 104
DO  - 10.5222/otd.2018.70431
ER  -